Back
Protagonist Therapeutics Vs. Manhattan Associates Industry Stock Comparison
Buy
57
PTGX
Protagonist Therapeutics
Last Price:
26.09
Seasonality Move:
28.29%
Sell
49
MANH
Manhattan Associates
Last Price:
210.80
Seasonality Move:
6.34%
Buy
57
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $26.09. The Score for PTGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Manhattan Associates (MANH)
is a Sell
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $210.76. The Score for MANH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- MANH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $26.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $210.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MANH is experiencing slight buying pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 46.72 | Sell |
Chaikin Money Flow: | -63474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.39 - 27.87) | Sell |
Bollinger Bands (100): | (23.44 - 29.1) | Sell |
MANH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.55 | Sell |
Relative Strength Index (14 RSI): | 31.82 | Sell |
Chaikin Money Flow: | 48155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (213.33 - 241.89) | Sell |
Bollinger Bands (100): | (215.35 - 250.31) | Sell |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.42 | Buy |
20-day SMA: | 26.29 | Sell |
50-day SMA: | 28.09 | Sell |
200-day SMA: | 21.93 | Buy |
8-day EMA: | 25.68 | Buy |
20-day EMA: | 26.24 | Sell |
50-day EMA: | 26.79 | Sell |
200-day EMA: | 23.61 | Buy |
MANH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 208.37 | Buy |
20-day SMA: | 223.63 | Sell |
50-day SMA: | 239.96 | Sell |
200-day SMA: | 217.28 | Sell |
8-day EMA: | 211.81 | Sell |
20-day EMA: | 221.25 | Sell |
50-day EMA: | 231.14 | Sell |
200-day EMA: | 216.88 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.51 per share.
Protagonist Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Manhattan Associates Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |